Structural, in silico, and functional analysis of a Disabled-2-derived peptide for recognition of sulfatides
Gottschalk, Carter J.
Ellena, Jeffrey F.
Finkielstein, Carla V.
Brown, Anne M.
Capelluto, Daniel G. S.
MetadataShow full item record
Disabled-2 (Dab2) is an adaptor protein that regulates the extent of platelet aggregation by two mechanisms. In the first mechanism, Dab2 intracellularly downregulates the integrin alpha (IIb)beta (3) receptor, converting it to a low affinity state for adhesion and aggregation processes. In the second mechanism, Dab2 is released extracellularly and interacts with the pro-aggregatory mediators, the integrin alpha (IIb)beta (3) receptor and sulfatides, blocking their association to fibrinogen and P-selectin, respectively. Our previous research indicated that a 35-amino acid region within Dab2, which we refer to as the sulfatide-binding peptide (SBP), contains two potential sulfatide-binding motifs represented by two consecutive polybasic regions. Using molecular docking, nuclear magnetic resonance, lipid-binding assays, and surface plasmon resonance, this work identifies the critical Dab2 residues within SBP that are responsible for sulfatide binding. Molecular docking suggested that a hydrophilic region, primarily mediated by R42, is responsible for interaction with the sulfatide headgroup, whereas the C-terminal polybasic region contributes to interactions with acyl chains. Furthermore, we demonstrated that, in Dab2 SBP, R42 significantly contributes to the inhibition of platelet P-selectin surface expression. The Dab2 SBP residues that interact with sulfatides resemble those described for sphingolipid-binding in other proteins, suggesting that sulfatide-binding proteins share common binding mechanisms.
- Open Access Subvention Fund Articles 
- Scholarly Works, Center for Soft Matter and Biological Physics 
- Scholarly Works, Department of Biochemistry 
- Scholarly Works, Department of Biological Sciences 
- Scholarly Works, Fralin Biomedical Research Institute at VTC 
- Scholarly Works, Fralin Life Sciences Institute 
- Scholarly Works, University Libraries 
- Scholarly Works, Virginia Tech Center for Drug Discovery